Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|October 5, 2023
Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast CancerChunlong Zhao, Yu Zhang, Jin'ge Zhang, et al.Circulation Research|June 3, 2021
Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart FailureJin-Ling Huo, Lemin Jiao, Qi An, et al.Molecules (Basel, Switzerland)|December 11, 2019
Investigating the Binding Mode of Reversible LSD1 Inhibitors Derived from Stilbene Derivatives by 3D-QSAR, Molecular Docking, and Molecular Dynamics SimulationYongtao Xu, Zihao He, Min Yang, et al.Theranostics|December 4, 2024
Unlocking the dual role of LSD1 in tumor immunity: innate and adaptive pathwaysYu Zhang, Ningjie Guo, Haoyi Zhu, et al.Bioinformatics (Oxford, England)|July 29, 2021
UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena dataShixiang Wang, Yi Xiong, Longfei Zhao, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 1, 2023
New insights into the non-enzymatic function of HDAC6Yuanzai Zhu, Mengkai Feng, Bo Wang, et al.Acta Pharmaceutica Sinica. B|August 7, 2019
Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)Zhonghua Li, Lina Ding, Zhongrui Li, et al.Cell Death & Disease|October 17, 2020
Correction: Potent and specific MTH1 inhibitors targeting gastric cancerWenjuan Zhou, Liying Ma, Jing Yang, et al.Cell Death & Disease|June 6, 2019
Potent and specific MTH1 inhibitors targeting gastric cancerWenjuan Zhou, Liying Ma, Jing Yang, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 25, 2024
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapyBinglei Zhang, Jianxiang Shi, Xiaojing Shi, et al.Pageof 5